New research and comprehensive resources for patients with microvillus inclusion disease

Microvillus inclusion disease (MVID) is a rare, genetic disease that causes chronic diarrhea in young babies. The amount of diarrhea often exceeds that of cholera, and infants will die unless they are given appropriate and often massive amounts of intravenous fluid. Patients with MVID often survive solely on IV fluids, also known as total parenteral nutrition or TPN, or they must undergo a small bowel transplant. Learn more about MVID.

At Vanessa Research we have patented and will soon begin clinical trials of a drug that has been developed to treat MVID – a treatment that will eliminate life-threatening diarrhea by encouraging immature cells in the intestine to grow normally and restore the absorption of fluids and nutrients. Learn more about our research.